Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04957277 · ClinicalTrials.gov registry record · NA

Stepping to Understand Lower Limb Impairments in Bilateral Cerebral Palsy

A NA study of Cerebral Palsy and Bilateral Cerebral Palsy, sponsored by Northwestern University.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04957277: Active NA study of Cerebral Palsy and Bilateral Cerebral Palsy, sponsored by Northwestern University.

NCT04957277 is a NA study of Cerebral Palsy and Bilateral Cerebral Palsy that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 30 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04957277, a NA study of Cerebral Palsy and Bilateral Cerebral Palsy, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate lower limb impairments in children with bilateral cerebral palsy during stepping tasks.

Primary Outcome

Sum of the joint kinetics from the hip, knee and ankle, termed the "support moment" and measured in Nm.

Interventions

  • OTHER load modulation

Study Locations (1)

Illinois

  • Northwestern University - Chicago

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-05-19
Est. Completion 2025-06
Phase NA
Northwestern University

1,209 total trials

What the registry record for NCT04957277 still lists

NCT04957277 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (87% lower).

The record links to 3 conditions, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which load modulation is the first listed.

NCT04957277 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04957277 about?

NCT04957277 is a clinical study titled "Stepping to Understand Lower Limb Impairments in Bilateral Cerebral Palsy". The purpose of this study is to investigate lower limb impairments in children with bilateral cerebral palsy during stepping tasks.

What is the current status of trial NCT04957277?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-05-19. Estimated completion is 2025-06.

What conditions does trial NCT04957277 study?

This clinical trial studies the following conditions: Cerebral Palsy, Bilateral Cerebral Palsy, Diplegic Cerebral Palsy.

What interventions are being tested in trial NCT04957277?

The interventions under investigation include: load modulation (OTHER).

Who is sponsoring clinical trial NCT04957277?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04957277 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04957277's enrollment target sits among peer trials

30 55th of 91 higher than 29 of 91 other Cerebral Palsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04957277, the US trial registry maintained by the National Library of Medicine. NCT04957277 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.